Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement

Stephen T Bartlett1, James F Markmann, Paul Johnson

  • 11 Department of Surgery, University of Maryland School of Medicine, Baltimore MD. 2 Division of Transplantation, Massachusetts General Hospital, Boston MA. 3 Nuffield Department of Surgical Sciences and Oxford Centre for Diabetes, Endocrinology, and Metabolism, University of Oxford, Oxford, United Kingdom. 4 Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden. 5 Schulze Diabetes Institute, Department of Surgery, University of Minnesota, Minneapolis, MN. 6 Prodo Laboratories, LLC, Irvine, CA. 7 The Scharp-Lacy Research Institute, Irvine, CA. 8 Department of Medicine, St. Vincent's Hospital, St. Vincent's Institute of Medical Research and The University of Melbourne Victoria, Australia. 9 Division of Transplantation, Department of Surgery, School of Medicine and Public Health, University of Wisconsin, Madison, WI. 10 Joslin Diabetes Center and Harvard Medical School, Boston, MA. 11 National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD. 12 Division of Transplantation, University of San Francisco Medical Center, San Francisco, CA. 13 Department of Surgery, Fukushima Medical University, Fukushima, Japan. 14 Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, PA. 15 Xenotransplantation Research Center, Department of Microbiology and Immunology, Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea. 16 The Center for Transplant and Renal Research, Westmead Millennium Institute, University of Sydney at Westmead Hospital, Westmead, NSW, Australia. 17 Diabetes Research Institute, School of Medicine, University of Miami, Coral Gables, FL. 18 National Center for Global Health and Medicine, Tokyo, Japan. 19 Otsuka Pharmaceutical Factory inc, Naruto Japan. 20 Department of Medicine III, Technische Universität Dresden, Dresden, Germany. 21 Paul Langerhans Institute Dresden of Helmholtz Centre Munich at University Clinic Carl Gustav

Transplantation
|February 4, 2016
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos

Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
2.2K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
2.5K
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.9K